- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Tracked and Traced at Every Stage?
Tracked and Traced at Every Stage?
If you are looking for totally compliant track and trace solutions? Look no further than Domino, the experienced coding partner.
Domino provides a complete range of solutions for variable printing applications offering interoperable coding platforms using laser, ink jet and RFID, with supporting software and connectivity.
They are experts in coding integrity and security solutions across a wide range of global industries with product traceability, using linear and composite codes such as Data Matrix including human readable information, at the core of their service offering.
Due to their unique industry knowledge, ensuring fully compliant solutions, the Integrated Solutions Group provide complete management support encompassing initial system design, migration and implementation strategy, installation, training and maintenance.
Need an industry partner? Choose Domino.
For more details click here
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
